Nussbaum Ran
Keros Therapeutics, Inc. · Director, 10% Owner
Nussbaum Ran is listed in filings as Director, 10% Owner at Keros Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 6, 2025, including 2 public disclosures. Recent filings connect the profile to Keros Therapeutics, Inc. (KROS). The current snapshot covers public activity from Jun 6, 2025. Reported amounts are shown as $155.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||